Lambda Therapeutics Research Ttd (LTRL)
Ahmedabad, Gujarat, 382481, India
NCT Number: NCT04256746
Randomized, balanced incomplete block design dose response study of efficacy, with 4 different dosages of mulberry fruit powdered extract added to cooked rice compared to a reference treatment (cooked rice only).
Looking for future studies?
Notify Me20 year–50 year
All sexes
Interventional
Not applicable
Ahmedabad, Gujarat, 382481, India
Dose response study with 4 dosages of mulberry fruit powdered extract (0.37, 0.75, 1.12 and 1.5 g) added to cooked rice, compared to cooked rice only(reference) on post prandial blood glucose response in healthy Indian adults.
In addition, 1.5 g of mulberry fruit powdered extract was added to instant rice porridge and compared to instant rice porridge only as positive control (replication of previous research.
In total there were 7 test products in the study: 5 active treatments and 2 reference treatments.
The study was a cross-over study (4 interventions per subject, 4 out of the 7 test products). The recovery period between treatments was at least seven days.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Positive incremental Area under the glucose versus time Curve between 0 (before) and 2 hours after test product intake
Glucose concentration in venous plasma
Time frame: Total area under the insulin versus time curves between 0 (before) and 2 hours after study product intake
Post-prandial serum insulin
Time frame: Analyzed before study product administration at 20 minutes before and at 65, 125, 185, 245, 305, 365 and 425 minutes after the ingestion of the study products
Each time a volunteer produced a 10 ppm hydrogen (or more) above the basal breath hydrogen level during the 7-hour test period, the value was regarded as a "positive".
Time frame: Just before and at 430 minutes after study product administration
A questionnaire to assess four aspects of intestinal discomfort (bloating, flatulence, nausea and pain) on scale from 0-3 was completed by the subjects
Unilever R&D
Industry
A Natural Extract for Reducing the Post Prandial Blood Glucose Response in Healthy Indian Adults: A Dose-response Study of Efficacy and Tolerance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07043478
Blood Glucose, Healthy
London, Ontario, Canada
View Trial DetailsNCT07187648
Blood Glucose, Blood-Borne Infections
Makassar, South Sulawesi, Indonesia
View Trial DetailsNCT06497972
Blood Glucose
Winnipeg, Manitoba, Canada
View Trial DetailsNCT06458946
Blood Glucose, Blood Insulin
Addison, Illinois, United States
View Trial Details